Business Focus
Clinical Focus
Spotlight
100 Years
CME/CE
Job Board
Mark Fuerst
Articles
More than one-third of hepatitis C patients denied insurance coverage
July 3rd 2018Despite the availability of new, highly successful direct-acting antiviral (DAA) regimens, more than one third of chronic hepatitis C (HCV) patients are denied access to treatment by their insurance provider, according to a new study.
